Gin Hwa Biotech Incorporation (7806.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$54.50 (-0.91%) as of
Key statistics
- Market cap
- 1.68B
- P/E (TTM)
- 28.09
- EPS (TTM)
- 1.94
- Dividend yield
- 1.82%
- 52-week range
- 54.00 – 77.62
- Revenue (TTM)
- 535.88M
- Profit margin
- 10.39%
- Volume
- 32.20k
About Gin Hwa Biotech Incorporation
Gin Hwa Biotech Incorporation manufactures and sells health supplements in Taiwan. The company offers nutritional supplements in various dosage forms, including soft gel encapsulations, tablets, capsules, liquids/ointments, powders, drop extracts, ready-to-drink, liquid sachets, pop rocks, tea bags, powder blends, ampoules, jellies, and other formats. Its products contain neuroboost, myorenew, dermaessence, cranbliss, and glycobalance ingredients. Gin Hwa Biotech Incorporation was founded in 2019 and is based in Kaohsiung, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Kaohsiung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.